Guiding ATMPs to patients
Here you can find information on what is happening in Sweden in development of medicines based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. We welcome your collaboration towards accelerated and effective patient solutions.
Register for ATMP Sweden 2020 in Stockholm!
Subscribe to our mailing list
Subscribe to receive our quarterly newsletter and updates on the next ATMP Sweden conference.
Follow us on LinkedIn!
Resources
Use our interactive map to find clinics, manufacture facilities and CAMP/Swelife-ATMP partners.
Use this guide to navigate development of your ATMP to Phase I!
What is the difference between a transplant and a cell based ATMP?
News
Anna Pasetto receives prestigious award to fight cancer with T cells
2020-01-08
Sjöberg foundation awards 6 million over 3 years to engineering of T cells against Hepatocellular Carcinoma
Read more
BOOSTB4 trial in Osteogenesis Imperfecta is recruiting!
2020-01-08
Please spread this information to those with patients relevant to this trial.
Read more
Events
Work with us!
Join our experts in the science and technology for GMP compliant clinical translation of ATMPs.
Join our experts in the knowledge, processes and competencies for getting ATMPs to patients.
Works with us towards making ‘Sweden a world leader advanced therapies by 2030’
ATMP success stories
Other collaborating national projects
VOG cell is responsible for ensuring Swedish GMP manfacturing facilities function at the highest level and are compliant with current regulations.
AdBIOPRO is developing Continuous Processing of emerging potent therapeutic products such as recombinant viral vector and cell Products.
This Group will be developing a long term strategy for the future of the ATMP field in Sweden. The Project will ensure that all necessary networks and stakeholders are involved.
See all ATMP relevant organisations here